Express Scripts 2012 Annual Report Download - page 119

Download and view the complete annual report

Please find page 119 of the 2012 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 120

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120

Gary G. Benanav1,4
Director
Retired Vice Chairman,
New York Life Insurance Company
Maura C. Breen3
Director, Chairman of the
Compensation Committee
Retired Senior Vice President,
Verizon Communications
William J. DeLaney2,3
Director
President and Chief Executive Officer,
Sysco Corporation
Nicholas J. LaHowchic4
Director, Chairman of the
Compliance Committee
President, Diannic LLC
Thomas P. Mac Mahon1
Presiding Director, Chairman of the
Corporate Governance Committee
Director and Retired Chairman and
Chief Executive Officer, Laboratory
Corporation of America Holdings (LabCorp)
Director, Chairman of Compensation Committee
and past Chairman of the Board
of PharMerica Corporation
Frank Mergenthaler2
Director, Chairman of the Audit Committee
Executive Vice President and
Chief Financial Officer,
Interpublic Group
Woodrow A. Myers Jr., MD MBA 4
Director
Managing Director, Myers Ventures LLC
John O. Parker Jr. 2,3
Director
Venture Partner,
Rho Ventures LLC
George Paz
Chairman of the Board
Chief Executive Officer,
Express Scripts
William L. Roper, MD, MPH4
Director
Dean, University of North Carolina (UNC)
School of Medicine
Vice Chancellor for Medical Affairs
Chief Executive Officer,
UNC Health Care System
Samuel K. Skinner1
Director
Former U.S. Secretary of Transportation and
Chief of Staff to President of United States
Retired Chairman and
Chief Executive Officer,
USF Corporation
Seymour Sternberg1,2
Director
Retired Chairman and Chief Executive Officer,
New York Life Insurance Company
1 Member of Corporate Governance Committee
2 Member of Audit Committee
3 Member of Compensation Committee
4 Member of Compliance Committee
Corporate Offices
Express Scripts Holding Company
One Express Way
St. Louis, MO 63121
314.996.0900
Annual Meeting
The 2013 Annual Meeting of Stockholders is
scheduled to be held on May 9, 2013, at
8:00 a.m. at our corporate headquarters,
One Express Way, St. Louis, MO 63121.
Holders
As of December 31, 2012, there were
approximately 63,776 stockholders of record
of our Common Stock. We estimate there are
approximately 677,224 beneficial owners of
our Common Stock.
Dividends
The Board of Directors has not declared any
cash dividends on our common stock since
the initial public offering. The Board of
Directors does not currently intend to declare
any cash dividends in the foreseeable future.
The terms of our existing credit facility and
the indenture under which our public debt
was issued contain certain restrictions on our
ability to declare or pay cash dividends.
Transfer Agent and Registrar
American Stock Transfer & Trust Company
6201 15th Avenue
Brooklyn, NY 11219
866.808.8310
Certifications
The certifications of George Paz, Chairman,
President and Chief Executive Officer and
Jeffrey Hall, Executive Vice President and
Chief Financial Officer, made pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
regarding the quality of Express Scripts’
public disclosure, have been filed as exhibits
to Express Scripts’ Annual Report on Form
10-K for the fiscal year ended December 31,
2012. These and other exhibits will be
furnished by the Investor Relations
department upon request.
Independent Accountants
PricewaterhouseCoopers LLP
800 Market Street
St. Louis, MO 63101
Board of Directors
Investor Relations Contact | 314.810.3115 | investor[email protected]